In an attempts to build on its expertise in the data analytics space, data analytics firm Saama Technologies is setting up a deep learning center in Pune.
Commenting on the development, Ken Coleman, Chairman, Saama Technologies told ET, “Pune will play an increasingly important role in our success. We are not in India for the low costs but to tap into the brain power”.
According to ET report, the firm was in the process of hiring people for the lab, which would work in collaboration with its existing engineering centre in the city.
The Company plans to sell this solution primarily to the customers in the US and Europe, which is where a bulk of the pharmaceutical research happens.
Not only this, Saama would also be increasing its headcount by 1520% by the end of this year. Though the company has operated across sectors, now it is focusing on specific verticals such as insurance, biotechnology, and pharma.
“The pharma and biotech industry is ripe for the use of analytics given the large amounts of data they generate. We have come up with a solution that offers clinical data analysis as a service which has resulted in a 15% reduction in costs and reducing the time spent on analyzing certain data from two years to six months,“ said Coleman.
Saama is unique in its ability to combine our Fluid Analytics Engine orchestration with their vertical industry expertise to drive the rapid adoption of advanced analytics into company-specific business processes in a matter of weeks. Saama has broad experience in projects including visualization, MDM, Hadoop, cloud and other advanced analytics solutions, in industries such as life sciences, healthcare, insurance, financial services, CPG, high-tech, and media.
Their clients include prominent names like Actelion, Bill and Melinda Gates Foundation, Brocade, Broadcom, Cisco, CSAA Insurance Group, Dignity Health, GoPro, Motorists Insurance Group, Otsuka, PayPal and Unilever.
Commenting on the development, Ken Coleman, Chairman, Saama Technologies told ET, “Pune will play an increasingly important role in our success. We are not in India for the low costs but to tap into the brain power”.
According to ET report, the firm was in the process of hiring people for the lab, which would work in collaboration with its existing engineering centre in the city.
The Company plans to sell this solution primarily to the customers in the US and Europe, which is where a bulk of the pharmaceutical research happens.
Not only this, Saama would also be increasing its headcount by 1520% by the end of this year. Though the company has operated across sectors, now it is focusing on specific verticals such as insurance, biotechnology, and pharma.
“The pharma and biotech industry is ripe for the use of analytics given the large amounts of data they generate. We have come up with a solution that offers clinical data analysis as a service which has resulted in a 15% reduction in costs and reducing the time spent on analyzing certain data from two years to six months,“ said Coleman.
Saama is unique in its ability to combine our Fluid Analytics Engine orchestration with their vertical industry expertise to drive the rapid adoption of advanced analytics into company-specific business processes in a matter of weeks. Saama has broad experience in projects including visualization, MDM, Hadoop, cloud and other advanced analytics solutions, in industries such as life sciences, healthcare, insurance, financial services, CPG, high-tech, and media.
Their clients include prominent names like Actelion, Bill and Melinda Gates Foundation, Brocade, Broadcom, Cisco, CSAA Insurance Group, Dignity Health, GoPro, Motorists Insurance Group, Otsuka, PayPal and Unilever.
Advertisements